Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA.

Michael P Hengartner; Martin Plöderl

doi:10.1177/20451253211032051

Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA.

Michael P Hengartner, Martin Plöderl (Last author)

Department of Psychiatry and Psychotherapy

Research output: Contribution to journal › Original Article › peer-review

10 Citations (Web of Science)

Original language	English
Pages (from-to)	20451253211032051
Journal	THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
Volume	11
DOIs	https://doi.org/10.1177/20451253211032051
Publication status	Published - 2021

Keywords

MAJOR DEPRESSIVE DISORDER
DISCONTINUATION
EFFICACY

Access to Document

10.1177/20451253211032051

Cite this

@article{98c9a2cc1bae4eaa9c0875b630afcd06,

title = "Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA.",

keywords = "MAJOR DEPRESSIVE DISORDER, DISCONTINUATION, EFFICACY",

author = "Hengartner, {Michael P} and Martin Pl{\"o}derl",

note = "Pl{\"o}derl: Department of Crisis Intervention and Suicide Prevention, University Clinic for Psychiatry, Psychotherapy, and Psychosomatics, Christian Doppler Clinic, Paracelsus Medical University Salzburg, Austria",

year = "2021",

doi = "10.1177/20451253211032051",

language = "English",

volume = "11",

pages = "20451253211032051",

journal = "THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY",

issn = "2045-1253",

}

TY - JOUR

T1 - Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA.

AU - Hengartner, Michael P

AU - Plöderl, Martin

N1 - Plöderl: Department of Crisis Intervention and Suicide Prevention, University Clinic for Psychiatry, Psychotherapy, and Psychosomatics, Christian Doppler Clinic, Paracelsus Medical University Salzburg, Austria

PY - 2021

Y1 - 2021

KW - MAJOR DEPRESSIVE DISORDER

KW - DISCONTINUATION

KW - EFFICACY

U2 - 10.1177/20451253211032051

DO - 10.1177/20451253211032051

M3 - Original Article

C2 - 34394912

SN - 2045-1253

VL - 11

SP - 20451253211032051

JO - THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY

JF - THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY

ER -